Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas
Status:
Recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
Study to asess the effects of Iberogast® (STW5) and Iberogast® N (STW5-II) in intestinal gas
transit and abdominal symptoms of patients suffering from irritable bowel syndrome or
functional dyspepsia.